Try our Advanced Search for more refined results

Hospira, Inc. et al v. Burwell et al

  1. September 05, 2014

    Hospira Can't Block Generic Precedex, Judge Rules

    A Maryland federal judge on Friday said the U.S. Food and Drug Administration's recent approval of generic versions of Hospira Inc.'s blockbuster sedative Precedex wasn't arbitrary or capricious, finding that the agency's decision was "entirely consistent" with its established practice of approving generic drugs.

  2. August 26, 2014

    Mylan Needn't Recall Generic Precedex In Battle With Hospira

    A Maryland federal judge on Tuesday amended a temporary restraining order that would have required Mylan Inc. and Par Sterile Products LLC to recall their generic versions of Hospira Inc.'s blockbuster sedative Precedex, saying he realized his initial decision went too far.

  3. August 20, 2014

    Mylan Wins Stay Of Generic Precedex Recall In Hospira Row

    A Maryland federal judge on Wednesday halted a recall of generic versions of Hospira Inc.'s blockbuster sedative Precedex at the request of Mylan Inc., but maintained a stay on the U.S. Food and Drug Administration's approval of generic versions of the drug.

  4. August 19, 2014

    Hospira Sues FDA Over Generic Precedex Carve-Out Approval

    Hospira Inc. hit the U.S. Food and Drug Administration with a suit on Monday contesting the agency's approval of generic versions of its blockbuster sedative Precedex, claiming the FDA violated its own rules in allowing generics for uses still protected by a Hospira patent.